Access member only content, take part in discussions with comments on blogs, news and reviews and receive all the latest security industry news directly to your inbox. Join now for free.
Processing registration... Please wait.
This process can take up to a minute to complete.
A confirmation email has been sent to your email address - SUPPLIED EMAIL HERE. Please click on the link in the email to verify your email address. You need to verify your email before you can start posting.
If you do not receive your confirmation email within the next few minutes, it may be because the email has been captured by a junk mail filter. Please ensure you add the domain @scmagazine.com.au to your white-listed senders.
Pharmaceutical group AstraZeneca accidentally sent out confidential internal corporate forecasts to financial analysts last week.
According to the Financial Times, it sent the emails on 5 January and a day later requested recipients destroy the information without accessing it.
“In line with its usual practice, the company will provide specific financial guidance for 2012 and any updates to 2010 to 2014 midterm planning assumptions, in conjunction with its full year 2011 financial results announcement, scheduled for 2 February 2012,” the company said in a statement.
Proofpoint vice-president of technology Andres Kohn said the breach was a classic "fat finger" mistake, but added AstraZeneca should have had policies and technology in place to ensure data was handled appropriately.
This article originally appeared at scmagazineuk.com
To begin commenting right away, you can log in below or register an account if you don't yet have one. Please read our guidelines on commenting. Offending posts will be removed and your access may be suspended. Abusive or obscene language will not be tolerated. The comments below do not necessarily reflect the views or opinions of SC Magazine, Haymarket Media or its employees.